Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 57 days ( -11.29 % )
Last Price $4.14 0 %
High/ Low $4.14 - $4.14 0%
Chg 7 Days N/A $4.14 $4.14
Chg 30 Days 11.29 % $3.72 $4.14
Chg 12 mos -25.41 % $5.55 $4.14
Trend - 3 mos 9.90 % Width: 9.39 %
Trend - 12 mos -8.35 % Width: 88.62 %
Pred. range - 3 mos $4.17 - $4.56 0.614 % - 10.06 %
Pred. range - 12 mos $2.63 - $4.96 -36.45 % - 19.88 %
Short MA avg 3 mos Sell Nov 30, -0001 - N/A days
Long MA avg 3 mos Sell Nov 30, -0001 - N/A days
Short/Long MA avg 3 mos Sell Aug 20, 2025 - 63 days
Short MA avg 12 mos Sell Aug 12, 2025 - 69 days
Long MA avg 12 mos Buy Oct 30, 2025 - 13 days
Short/Long MA avg 12 mos Buy Nov 05, 2025 - 9 days
Pivot Short Sell Nov 14, 2025 - 2 days
Bollinger Sell Nov 30, -0001 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT GENFIT
Genfit
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE